Fintel reports that on May 5, 2025, Benchmark initiated coverage of Marti Technologies (NYSEAM:MRT) with a Buy recommendation.
Analyst Price Forecast Suggests 68.87% Upside
As of April 24, 2025, the average one-year price target for Marti Technologies is $5.10/share. The forecasts range from a low of $3.03 to a high of $7.35. The average price target represents an increase of 68.87% from its latest reported closing price of $3.02 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Marti Technologies is 18MM, a decrease of 4.74%. The projected annual non-GAAP EPS is -0.44.
What is the Fund Sentiment?
There are 16 funds or institutions reporting positions in Marti Technologies. This is an increase of 4 owner(s) or 33.33% in the last quarter. Average portfolio weight of all funds dedicated to MRT is 0.11%, an increase of 1,180.29%. Total shares owned by institutions increased in the last three months by 161.63% to 7,160K shares.
What are Other Shareholders Doing?
DLD Asset Management holds 3,586K shares representing 4.70% ownership of the company. In its prior filing, the firm reported owning 60K shares , representing an increase of 98.33%. The firm increased its portfolio allocation in MRT by 8,829.90% over the last quarter.
Gramercy Funds Management holds 1,831K shares representing 2.40% ownership of the company. In its prior filing, the firm reported owning 1,757K shares , representing an increase of 4.01%.
Weiss Asset Management holds 606K shares representing 0.79% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Wells Fargo holds 500K shares representing 0.66% ownership of the company. In its prior filing, the firm reported owning 200K shares , representing an increase of 60.00%. The firm increased its portfolio allocation in MRT by 42.06% over the last quarter.
Luxor Capital Group holds 267K shares representing 0.35% ownership of the company. In its prior filing, the firm reported owning 24K shares , representing an increase of 91.11%. The firm increased its portfolio allocation in MRT by 2,119.59% over the last quarter.
MedEquities Realty Trust Background Information
(This description is provided by the company.)
MedEquities Realty Trust, Inc. operates as a real estate investment trust. It focuses on investment in healthcare properties and healthcare related real estate debt investments. The firm owns, develops, operates, leases, and disposes healthcare properties and portfolios. The company was founded in April 23, 2014 and is headquartered in Nashville, TN.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
